Full Potential - Health Technology Insights

TRI Unveils Upgraded OPRA-CM to Enhance Centralized Monitoring in Clinical Trials

June 3, 2025

TRI, a leading innovator in Risk-Based Quality Management technology, announced the launch of the latest version of OPRA-CM, a reimagined centralized monitoring platform built to

Stylus Medicine Launches to Advance Precision In Vivo Genetic Medicines

May 13, 2025

$85 million in financing includes recent $45 million Series A extension with participation from founding investors RA Capital Management and Khosla Ventures and six new

Categories

Tag: Full Potential

TRI Unveils Upgraded OPRA-CM to Enhance Centralized Monitoring in Clinical Trials

Stylus Medicine Launches to Advance Precision In Vivo Genetic Medicines

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 23 September 2025

AmeriPro Health Elects Larry Richardson as Board Chairman

Julius Clinical Welcomes Bassem Saleh as Chief Executive Officer

Shotsy Appoints Eric Perakslis as Chief Science Officer

LogicMark Launches Predictive Activity Metrics in Freedom Alert Max Device

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands